-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 D9AgfN29hQM2hGJA/MXfz0aY4gWDS8JZ+QOiLAnddZ3IZXqi0X/TGL6wIL3i6uK6
 JOUZTXVrKRcoBoRfI2D36Q==

<SEC-DOCUMENT>/in/edgar/work/20000630/0000936392-00-000362/0000936392-00-000362.txt : 20000920
<SEC-HEADER>0000936392-00-000362.hdr.sgml : 20000920
ACCESSION NUMBER:		0000936392-00-000362
CONFORMED SUBMISSION TYPE:	RW
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20000630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIGNAL PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001029201
		STANDARD INDUSTRIAL CLASSIFICATION:	 [8731
]		IRS NUMBER:				943174286
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231
</COMPANY-DATA>

		FILING VALUES:
			FORM TYPE:		RW
			SEC ACT:		
			SEC FILE NUMBER:	333-30730
			FILM NUMBER:		665866
</FILING-VALUES>

			BUSINESS ADDRESS:	
				STREET 1:		5555 OBERLIN DR
				CITY:			SAN DIEGO
				STATE:			CA
				ZIP:			92121
				BUSINESS PHONE:		6195587500
</BUSINESS-ADDRESS>

				MAIL ADDRESS:	
					STREET 1:		5555 OBERLIN DRIVE
					CITY:			SAN DIEGO
					STATE:			CA
					ZIP:			92121
</MAIL-ADDRESS>
</FILER>
</SEC-HEADER>
<DOCUMENT>
<TYPE>RW
<SEQUENCE>1
<FILENAME>rw.txt
<DESCRIPTION>WITHDRAWAL REQUEST
<TEXT>

<PAGE>   1
                          SIGNAL PHARMACEUTICALS, INC.
                               5555 OBERLIN DRIVE
                              SAN DIEGO, CA  92121


June 29, 2000

VIA EDGAR TRANSMISSION

Securities and Exchange Commission
450 Fifth Street, N.W.
Judiciary Plaza
Washington, DC  20549

RE:  SIGNAL PHARMACEUTICALS, INC.
     REGISTRATION STATEMENT ON FORM S-1 (NO. 333-30730)
     APPLICATION FOR WITHDRAWAL

Ladies and Gentlemen:

The undersigned registrant hereby makes application, pursuant to paragraph (a)
of Rule 477 under the Securities Act of 1933, as amended, to withdraw its
Registration Statement on Form S-1 (SEC File No. 333-30730) filed with the
Commission on February 18, 2000 and amended on March 22, 2000.  This application
is made on the grounds that, based on current market conditions, the undersigned
registrant has determined that it is not advisable at this time to proceed with
the proposed offering.

If you should have any questions regarding this application, please contact
Denise Woolard or Jennifer DeTrani of Cooley Godward LLP at (858) 550-6000.

Sincerely,

SIGNAL PHARMACEUTICALS, INC.


By:  /s/ Alan J. Lewis
     Alan J. Lewis
     President and Chief Executive
     Officer


cc:  Mr. Bradley B. Gordon
     Frederick T. Muto, Esq.
     L. Kay Chandler, Esq.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----